Kensuke Nomura

Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia

Takefumi Suzuki, Hiroyuki Uchida, Kenji F. Tanaka et al. · The International Journal of Neuropsychopharmacology · 2004 · 130 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +16

Augmentation of atypical antipsychotics with valproic acid. An open‐label study for most difficult patients with schizophrenia

Takefumi Suzuki, Hiroyuki Uchida, Hiroyoshi Takeuchi et al. · Human Psychopharmacology Clinical and Experimental · 2009 · 56 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?—A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting

Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe et al. · Psychopharmacology · 2007 · 53 citations

Pharmacy, Pharmacotherapy, Psychiatry +15

Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open‐label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone

Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe et al. · Human Psychopharmacology Clinical and Experimental · 2008 · 50 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy

Issei Takeuchi, Kensuke Nomura, Kimiko Makino · Colloids and Surfaces B Biointerfaces · 2017 · 40 citations

Pharmacy, Materials Engineering, Materials Science +13